Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amonafide in Metastatic Breast Cancer
NCT00074100Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Aug 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amonafide in breast cancer, sponsored by Memorial Sloan Kettering Cancer Center. Started Aug 2003; status: completed.
02
Drugs
amonafide
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00074100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00074100.